The differentiation of new human CD303+ Plasmacytoid dendritic cell subpopulations expressing CD205 and/or CD103 regulated by Non-Small-Cell lung cancer cells
- PMID: 34298400
- DOI: 10.1016/j.intimp.2021.107983
The differentiation of new human CD303+ Plasmacytoid dendritic cell subpopulations expressing CD205 and/or CD103 regulated by Non-Small-Cell lung cancer cells
Abstract
CD303+ plasmacytoid dendritic cells (pDCs) play an important role in the induction of immune tolerance and antitumor immunity. Here, we focused on the effect of NSCLC cells on the development of CD303+ pDC subsets expressing CD205 and/or CD103. The NSCLC cell line H1299 and primary NSCLC cells were incubated with DCs. The protein expression of costimulatory molecules on CD303+ pDCs, the production of pro-inflammatory and anti-inflammatory cytokines by CD303+ pDCs and the development of CD303+ pDC subsets were detected by using flow cytometry. Coculture with NSCLC cells modulates the protein expression of CD86 and HLA-DR on CD303+ pDCs. Moreover, NSCLC cells suppressed the production of IL-12 and IL-23 but facilitated the secretion of IL-27 and TGF-β by CD303+ pDCs. There were new CD303+ pDC subsets expressing CD205 and/or CD103 in healthy donors and NSCLC patients: CD303+CD205+CD103+, CD303+CD205+CD103-, CD303+CD205-CD103+ and CD303+CD205-CD103- pDCs. NSCLC cells modulated the differentiation of CD303+ pDC subpopulations by regulating the protein expression of CD205 and/or CD103 on CD303+ pDCs. NSCLC cells may regulate the immune functions of CD303+ pDCs by modulating the expression of costimulatory molecules on DCs and the production of pro-inflammatory/anti-inflammatory cytokines by DCs. NSCLC cells also regulate the development of CD303+ pDC subsets expressing CD205 and/or CD103. These outcomes may reveal a new cellular mechanism leading to the NSCLC-induced immune-suppressive microenvironment.
Keywords: Immune tolerance; Immunotherapy; Non-small-cell lung cancer; Plasmacytoid dendritic cell; Subset.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
Non-small Cell Lung Cancer Cells Modulate the Development of Human CD1c+ Conventional Dendritic Cell Subsets Mediated by CD103 and CD205.Front Immunol. 2019 Dec 10;10:2829. doi: 10.3389/fimmu.2019.02829. eCollection 2019. Front Immunol. 2019. PMID: 31921114 Free PMC article.
-
CD1c+ and CD303+ dendritic cells in peripheral blood, lymph nodes and tumor tissue of patients with non-small cell lung cancer.Oncol Rep. 2008 Jan;19(1):237-43. Oncol Rep. 2008. PMID: 18097601
-
Analysis of DC Functions Using CD205-DTR Knock-In Mice.Methods Mol Biol. 2016;1423:291-308. doi: 10.1007/978-1-4939-3606-9_21. Methods Mol Biol. 2016. PMID: 27142025
-
CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.Leuk Lymphoma. 2022 Jan;63(1):19-30. doi: 10.1080/10428194.2021.1975192. Epub 2021 Sep 6. Leuk Lymphoma. 2022. PMID: 34486917 Review.
-
Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?Front Cell Infect Microbiol. 2020 May 26;10:249. doi: 10.3389/fcimb.2020.00249. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32528903 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials